The ever-broadening scope of pharmaceuticals now available to treat previously untreatable
conditions, such as advanced metastatic cutaneous melanoma, have resulted in unintended …

In rare cases, bisphosphonates are well established to cause ocular inflammation,
presenting as uveitis, episcleritis, scleritis, orbital inflammation, and/or conjunctivitis. Some …

Objective: To evaluate the efficacy of a single dose of intravenous zoledronate for the
treatment of HIV-associated osteopenia and osteoporosis. Design: A double-blinded …

Ocular inflammatory reactions have been described in patients on bisphosphonate
treatment. We estimated the incidence rate of ocular inflammation at 3 and 12 months in …

Drug-induced uveitis has become increasingly recognized in association with a number of
commonly used systemic, intraocular, and topical medications. A detailed history is often all …

Treatments of numerous systemic and local diseases of different etiologies may be
accompanied by an unwanted side effect in the form of uveitis. We inform readers about …

Background/Aims: To highlight the potential ocular side effects of bisphosphonate therapy
and the importance of a proper drug history in patients who present with uveitis. Methods …

The orthodontic treatment of patients on bisphosphonates is becoming an increasing aspect
of contemporary practice. This article will draw attention to the chemical structure and effects …

The use of aromatase inhibitors (AIs) as adjuvant endocrine therapy for hormone-sensitive
breast cancer is increasing, as these drugs are more effective than tamoxifen alone in …

Introduction: Zoledronate is commonly prescribed medication to maintain bone health
however, a rare side effect includes ocular inflammation. We report a case of simultaneous …